Tyler P. Lipschultz
Independent DirectorMr. Tyler P. Lipschultz is Independent Director of Xtant Medical Holdings, Inc. from August 4, 2025. He was Senior Vice President of Orthobiologics and Business Development at SeaSpine Holdings Corp. since February 2018. He serves as President of LocateBio, Inc., a U.S. subsidiary of a biotechnology company in England, a position he has held since November 2024. He served as President of Global Biologics at Orthofix Medical Inc. since January 4, 2023. Mr. Lipschultz served as Vice President of Orthobiologics & Business Development at SeaSpine Holdings Corporation from July 20, 2015 to February 2018. Mr. Lipschultz ws responsible for Orthobiologics marketing and development, as well as business development for all of SeaSpine. Mr. Lipschultz served as an Executive Vice President of Global Operations at NuVasive, Inc. since November 2011. Mr. Lipschultz served as an Executive Vice President of Biologics at NuVasive, Inc. from January 2011 to November 2011. From July 2008 to December 2010, he served as Senior Vice President of Biologics. From June 2008 to March 2015, Mr. Lipschultz held positions of increasing responsibility at NuVasive, Inc., a publicly traded medical device company, most recently serving as its executive vice president, global operations and prior to that, executive vice president, biologics. He co-founded Annulex, CVRx and VERTx. In 2002, VERTx merged with Spine Wave, where Mr. Lipschultz subsequently served in a variety of roles, including executive vice president and general manager of the mechanical business. From March 2002 to June 2008, Mr. Lipschultz was the Founder and Vice President, Executive Vice President and General Manager of Spine Wave Inc. Mr. Lipschultz has years of sales, marketing and operational leadership experience in spine and general orthopedic devices and with the medical device industry including: Director of Protostar, a medical device incubator and President of VERTx, a private company founded by ProtoStar and later merged with Spine Wave; Equity Research Analyst at US BanCorp and Piper Jaffray Inc. (also known as Piper Jaffray Companies, Research Division) where he was focused on orthopaedic and spinal markets; and various marketing positions at DePuy, Inc., Smith & Nephew and Stryker, Inc. Mr. Lipschultz received a B.A. focused in Economics and Business Administration from Kalamazoo College and an M.B.A. from the executive program at Krannert School of Management at Purdue University.
公司职务
- 公司名称Xtant Medical Holdings, Inc.股票代码XTNT职务Independent Director共事同僚
- SESean E. BrownePresident, CEO & Director
- SGStavros George VizirgianakisIndependent Chairman
- SCScott C. NeilsChief Financial Officer
- MAMark A. SchallenbergerChief Operations Officer
- CLCatherine LundyVice President of Human Resources
- JKJohn K. BakewellIndependent Director
- JRJonn R. BeesonIndependent Director
